Fundraising Fox

Camp4 Therapeutics Corp

NASDAQ: CAMP

Cambridge, US · Founded 2015 · Delaware corporation · 4 known investors

Biotech

Founders & leadership

RY
RICHARD YOUNGDirector
MH
MICHAEL HIGGINSDirector
JC
JORGE CONDEDirector
JM
JOSH MANDEL-BREHMExecutive Officer, Director
AN
AMIR NASHATDirector

Investors · 4

5AM VenturesreportedBoston · $100K – $4Mvia Andy Schwab · board
Andreessen HorowitzreportedMenlo Park · $500K – $50Mvia Jorge Conde · board
Longwood FundreportedBostonvia Shaan C. Gandhi · board
Polaris PartnersreportedBoston · $500K – $5Mvia Amir Nashat · board

Reported raises · per SEC filings

Form D private placements
▶$100.5MraisedJun 2022 · 16 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • PAULA RAGANDirector
  • STEVE HOLTZMANDirector
  • MICHAEL HIGGINSDirector
  • RAVI I. THADHANIDirector
  • RICHARD YOUNGDirector
  • AMIR NASHATDirector
  • CALEB MOOREExecutive Officer
  • JORGE CONDEDirector
  • SHAAN GANDHIDirector
  • JOSH MANDEL-BREHMExecutive Officer, Director
  • ANN BARBIERExecutive Officer
  • ALFICA SEHGALExecutive Officer
  • MICHELLE GATESExecutive Officer
  • KELLY GOLDExecutive Officer
  • DAVID BUMCROTExecutive Officer
  • ANDREW J. SCHWABDirector
  • JAMES BOYLANDirector
Amount sold
$100.5M
First sale
Jun 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$45MraisedOct 2021 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • JORGE CONDEDirector
  • RAVI THADHANIDirector
  • ALFICA SEHGALExecutive Officer
  • SHAAN GANDHIDirector
  • PAULA RAGANDirector
  • MICHELLE GATESExecutive Officer
  • STEVE HOLTZMANDirector
  • CALEB MOOREExecutive Officer
  • MICHAEL HIGGINSDirector
  • AMIR NASHATDirector
  • KELLY GOLDExecutive Officer
  • RICHARD YOUNGDirector
  • JOSH MANDEL-BREHMExecutive Officer, Director
  • ANDY SCHWABDirector
  • DAVID BUMCROTExecutive Officer
Amount sold
$45M
First sale
Mar 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$34.1MraisedSep 2018 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • RICHARD YOUNGDirector
  • MICHAEL HIGGINSDirector
  • JORGE CONDEDirector
  • JOSH MANDEL-BREHMExecutive Officer, Director
  • AMIR NASHATDirector
Offering amount
$34.1M
Amount sold
$34.1M
First sale
Apr 2018
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.